1,799 results match your criteria: "Kidney Research Institute[Affiliation]"
Cardiovasc Diabetol
October 2024
Department of Social Epidemiology, Graduate School of Medicine, Kyoto University, Yoshida-Konoecho, Sakyo-Ku, Kyoto-Shi, Kyoto, 6068315, Japan.
J Clin Invest
October 2024
Department of Pediatrics, Section of Endocrinology, University of Colorado School of Medicine, Aurora, Colorado, USA.
BACKGROUNDIn type 1 diabetes (T1D), impaired insulin sensitivity may contribute to the development of diabetic kidney disease (DKD) through alterations in kidney oxidative metabolism.METHODSYoung adults with T1D (n = 30) and healthy controls (HCs) (n = 20) underwent hyperinsulinemic-euglycemic clamp studies, MRI, 11C-acetate PET, kidney biopsies, single-cell RNA-Seq, and spatial metabolomics to assess this relationship.RESULTSParticipants with T1D had significantly higher glomerular basement membrane (GBM) thickness compared with HCs.
View Article and Find Full Text PDFJ Nephrol
October 2024
Department of Translational Medicine, Seoul National University College of Medicine, Seoul, Korea.
Background: Hormone replacement therapy (HRT) is recommended for alleviating vasomotor symptoms or preventing bone loss in postmenopausal women. This study aimed to investigate the impact of hormone replacement therapy on major adverse cardiovascular events, kidney failure, and mortality in women with chronic kidney disease (CKD).
Methods: This population-based cohort study analyzed data from the National Cancer Screening Program and the national health examination of South Korea.
Front Nutr
September 2024
Department of Nephrology, Kidney Research Institute, West China Hospital, Sichuan University, Chengdu, China.
Introduction: Oxidative stress plays a pivotal role in the pathogenesis of chronic kidney disease (CKD). The oxidative balance score (OBS) was devised to quantify the overall oxidative state, integrating pro-oxidant and antioxidant influences from both dietary intake and lifestyle practices. The aim of this study was to delve into the relationship between the OBS and CKD within the adult population of the United States.
View Article and Find Full Text PDFTransplant Direct
November 2024
Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, South Korea.
Nephron
October 2024
Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University/West China School of Nursing, Sichuan University, Chengdu, China.
Introduction: Middle-aged and older individuals often face significant challenges in adopting digital health solutions, leading to a digital divide that hinders their ability to benefit from mobile health (mHealth) interventions. This study aimed to investigate the specific requirements of middle-aged and older patients with chronic kidney disease (CKD) for self-management through mobile health applications (mHealth apps), using the Kano model.
Methods: A multicenter cross-sectional survey was conducted from April to September 2023 in five hospitals across Sichuan, Shandong, Guangdong, and Shaanxi provinces in China.
Kidney Res Clin Pract
September 2024
Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Kidney Res Clin Pract
September 2024
Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.
Background: Since hemodialysis (HD) patients are prone to various complications and high mortality, they need to be treated in HD units with professional personnel, proper equipment, and facilities. The Korean Society of Nephrology has been conducting an HD unit accreditation program since 2016. This study was performed to evaluate whether a qualified dialysis center (QDC) reduced the mortality of HD patients.
View Article and Find Full Text PDFKidney Res Clin Pract
September 2024
Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.
Ren Fail
December 2024
Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu, Sichuan, PR China.
Exp Mol Med
October 2024
Kidney Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Clin Transl Gastroenterol
November 2024
Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington, USA.
Cell Commun Signal
October 2024
Department of Kidney Research Institute, Seoul National University Medical Research Center, Seoul, Republic of Korea.
Thromb J
October 2024
Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu, China.
BMC Psychiatry
October 2024
Nursing Department of West China Hospital, Sichuan University, No.37 Guoxuexiang Wuhou District, Chengdu, Sichuan Province, China.
Kidney Med
November 2024
Division of Nephrology, Department of Medicine, New York University Grossman School of Medicine, New York, New York.
Acta Diabetol
September 2024
Nephrology Department, Linkou Medical Center, College of Medicine, Kidney Research Institute Chang Gung Memorial Hospital Chang Gung University, No.5, Fuxing Street, Guishan District, Taoyuan, 33305, Taiwan.
Aims: PPAR-gamma shows promise in inhibiting malignancy cell progression. However, pioglitazone, the sole current PPAR-gamma agonist, was reported to have risks of bladder cancer in previous clinical researches. This study is aimed to assess the influence of pioglitazone on the development of tumors.
View Article and Find Full Text PDFNat Commun
September 2024
Department of Anesthesiology, Laboratory of Anesthesia and Critical Care Medicine, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Open Med (Wars)
September 2024
Kidney Research Institute, Division of Nephrology, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, Sichuan, China.
Objective: The aim of this study was to investigate iron status and iron deficiency in incident continuous ambulatory peritoneal dialysis (CAPD) patients and identify influencing factors.
Methods: Patients with end-stage renal disease were enrolled. Clinical data of iron metabolism and biochemical and dialysis parameters during the first peritoneal dialysis evaluation were collected.
BMJ Open
September 2024
Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu, China.
Disaster Med Public Health Prep
September 2024
School of Nursing, The Hong Kong Polytechnic University, Kowloon, Hum Hung, China.
Background: Patients undergoing maintenance hemodialysis face heightened vulnerability during disasters like tropical cyclones, yet there is sparse research on their treatment-related challenges and countermeasures. This scoping review aims to highlight the issues maintenance hemodialysis patients encounter following tropical cyclones.
Methods: A systematic scoping review of 19 articles from 2000 to 2023 was conducted, evaluating eligibility against predefined criteria.
Nat Commun
September 2024
College of Chemistry, Sichuan University, Chengdu, China.
Allosteric drugs offer a new avenue for modern drug design. However, the identification of cryptic allosteric sites presents a formidable challenge. Following the allostery nature of residue-driven conformation transition, we propose a state-of-the-art computational pipeline by developing a residue-intuitive hybrid machine learning (RHML) model coupled with molecular dynamics (MD) simulation, through which we can efficiently identify the allosteric site and allosteric modulator as well as reveal their regulation mechanism.
View Article and Find Full Text PDFBlood Purif
January 2025
Division of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu, China.
JAMA Netw Open
September 2024
Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence Rhode Island.
Importance: In January 2021, under the 21st Century Cures Act, Medicare beneficiaries with end-stage renal disease (ESRD) were permitted to enroll in private Medicare Advantage (MA) plans for the first time. In the first year of the Cures Act, there was a 51% increase in MA enrollment among beneficiaries with ESRD.
Objective: To examine changes in MA enrollment among Medicare beneficiaries with ESRD in the first 2 years of the Cures Act and, among beneficiaries newly enrolled in MA in 2021, to assess the proportion of beneficiaries who switched MA contracts and how the characteristics of contracts changed.
Pediatr Nephrol
December 2024
Division of Nephrology, Department of Pediatrics, The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Pennsylvania, PA, USA.